Method of differentiating stem cells
The present disclosure provides methods of generating germ layers from stem cells comprising culturing the stem cells in a culture medium having an osmolality less than 340 mOsm/kg. The present disclosure also includes a method to generate different cell lineages from the germ layers as well as to detect them by immunological methods. The present disclosure further provides methods for the generation, isolation, cultivation and propagation of committed progenitor cells and for the production of differentiated cells from the three germ layers. The present disclosure also provides culture media for use in inducing the three germ layers.
1. A method of generating a population of ectodermal progenitor cells comprising:
a) dissociating a culture of undifferentiated pluripotent stem cells;
b) differentiating the dissociated undifferentiated pluripotent stem cells into a population of progenitor cells enriched for ectodermal fate by culturing the dissociated undifferentiated pluripotent stem cells from a) in suspension and/or in a microwell device in culture media with an osmolality of 260 to 280 mOsm/kg for at least 1 day; and
c) dissociating the population of cells enriched for ectodermal fate generated in step b) and plating the cells onto coated culture dishes and culturing for at least 1 day in said culture media to produce the ectodermal progenitor cells as adhered cultures,
wherein the cells in step b) are enriched for ectodermal fate when the percentage of colonies of the adhered cultures of step c) containing more than 50% by area rosettes is greater than the percentage of colonies of adhered cultures containing more than 50% by area rosettes when cultured in culture media with an osmolality outside of the range of 260 to 280 mOsm/kg.
2. The method of claim 1 , wherein culturing the dissociated undifferentiated cells in suspension and/or in the microwell device in b) comprises
i) culturing the dissociated undifferentiated pluripotent stem cells from a) in the microwell device for about 24 hours to form aggregates and continuing the culture in the microwell device for more than 24 hours in the culture media followed by releasing the aggregates and adhering onto coated culture dishes and culturing in the culture media for at least 1 day;
ii) culturing the dissociated undifferentiated pluripotent stem cells from a) in the culture media in the microwell device for about 24 hours to form aggregates, releasing the aggregates from the microwell device, followed by culturing the released aggregates in suspension in the culture media for at least 1 day, dissociating and adhering the aggregates onto coated culture dishes and culturing in the culture media for at least 1 day; or
iii) culturing the dissociated undifferentiated pluripotent stem cells from a) in suspension in the culture media for at least 1 day followed by dissociating the cells and adhering onto coated culture dishes and culturing in the culture media for at least 1 day.
3. The method of claim 2 , wherein the aggregates comprise 500 to 20,000 cells.
4. The method of claim 1 , wherein the pluripotent stem cells are mammalian induced pluripotent stem cells or mammalian embryonic stem cells.
5. The method of claim 4 , wherein the pluripotent stem cells are human induced pluripotent stem cells or human embryonic stem cells.
6. A method of maintaining single neural progenitor cells for at least 3 passages in culture media with an osmolality of 260-340 mOsm/kg comprising generating ectodermal progenitor cells according to the method of claim 1 ; dissociating the ectodermal progenitor cells from the adhered cultures; plating and culturing said progenitor cells for at least 1 day.
7. The method of claim 6 , wherein the cells are dissociated with a buffered solution comprising a Ca 2+ and Mg 2+ free buffer solution comprising 1×PBS or 1× Hank's Buffered Salt Solution with a pH range of pH 7.0 to pH 8.0.
8. The method of claim 6 , wherein the neural progenitor cells are further differentiated to form neurons, astrocytes and/or oligodendrocytes.
9. A method of screening germ layer cells comprising
(a) preparing a culture of ectodermal germ layer cells according to the method of claim 1 ;
(b) treating the germ layer cells with a test agent or agents; and
(c) subjecting the treated germ layer cells to analysis.
10. The method of claim 1 , wherein said culture media does not include GABA, pipecolic acid, bFGF, TGFβ1, and lithium chloride.
11. The method of claim 1 , wherein dissociating the population of cells enriched for ectodermal fate generated in step b) comprises applying a Ca 2+ and Mg 2+ free buffer solution comprising 1× PBS or 1× Hank's Buffered Salt Solution with a pH range of pH 7.0 to pH 8.0.
12. The method of claim 1 , wherein said culture media is serum-free.
13. A method of generating a population of ectodermal progenitor cells comprising:
a) dissociating a culture of undifferentiated pluripotent stem cells;
b) differentiating the dissociated undifferentiated pluripotent stem cells into a population of progenitor cells enriched for ectodermal fate by culturing the dissociated undifferentiated pluripotent stem cells from a) in a monolayer culture in culture media with an osmolality of 270 to 320 mOsm/kg for at least 1 day; and
c) dissociating the population of cells enriched for ectodermal fate generated in step b) and plating the cells onto coated culture dishes and culturing for at least 1 day in said culture media to produce the ectodermal progenitor cells as adhered cultures.
14. The method of claim 13 , wherein culturing the dissociated undifferentiated pluripotent stem cells in the monolayer culture in b) comprises adhering the dissociated undifferentiated pluripotent stem cells from a) onto coated culture dishes or feeders and culturing for at least 3 days in the culture media.
15. The method of claim 13 , wherein the pluripotent stem cells are mammalian induced pluripotent stem cells or mammalian embryonic stem cells.
16. The method of claim 15 , wherein the pluripotent stem cells are human induced pluripotent stem cells or human embryonic stem cells.
17. The method of claim 13 , wherein said culture media does not include GABA, pipecolic acid, bFGF, TGFβ1, and lithium chloride.
18. The method of claim 13 , wherein said culture media is serum-free.